15.05.2013 08:50 Uhr, Quelle: Presseportal

SYGNIS reports results for the first quarter of 2013

SYGNIS Pharma AG: Madrid/Heidelberg (ots) - - Operating expenses decreased by over 50 percent - Operating result significantly improved - U.S. patent for flagship product QualiPhi® (after period-end) - Outlook confirmed SYGNIS Pharma AG

Weiterlesen bei Presseportal